Aegerion Pharmaceuticals, Inc. (AEGR) Posts Q1 Loss of 55c/Share

Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) reported Q1 EPS of ($0.55), $0.01 worse than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Aegerion Pharmaceuticals, Inc. (AEGR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• InspireMD (NSPR) Tops Q2 EPS by 1c
• Yum! Brands (YUM) PT Lowered to $180 at Argus